Melatonin and the metabolic syndrome: a tool for effective therapy in obesity‐associated abnormalities?
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome (M et S) is a cluster of metabolic abnormalities associated with increased risk for cardiovascular diseases. Apart from its powerful antioxidant properties, the pineal gland hormone melatonin has recently attracted the interest of various investigators as a multifunctional molecule. Melatonin has been shown to have beneficial effects in cardiovascular disorders including ischaemic heart disease and hypertension. However, its role in cardiovascular risk factors including obesity and other related metabolic abnormalities is not yet established, particularly in humans. New emerging data show that melatonin may play an important role in body weight regulation and energy metabolism. This review will address the role of melatonin in the M et S focusing on its effects in obesity, insulin resistance and leptin resistance. The overall findings suggest that melatonin should be exploited as a therapeutic tool to prevent or reverse the harmful effects of obesity and its related metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
Global burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319 · cited 2×
“Previous strategies to combat the prevalence of obesity and the MetS have not yet been successful and it is predicted that up to 58% of the global adult population could be either overweight or obese by 2030 (Kelly et al. 2008).”
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 1×
“…oxidative stress and eventual antioxidant interventions in obesity and insulin resistant states will not be discussed since they have been largely reviewed elsewhere (Houstis et al. 2006, Vincent et al. 2007, Grattagliano et al. 2008, Hopps et al. 2010, Otani 2011, Rains & Jain 2011).”
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 2×
“Furthermore, several melatonin metabolites (e.g., N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK)) which are formed when melatonin neutralizes damaging reactants are themselves free radical scavengers (Tan et al. 2007, Reiter et al. 2008).”
Mechanisms of leptin action and leptin resistance.
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074 · cited 2×
“…of leptin resistance and impaired leptin signaling includes amongst other things increased activity of suppressor of cytokine signaling 3 (SOCS3) (Bjorbaek et al. 1999, Emilsson et al. 1999) which is a member of a family of proteins which inhibits the JAK-STAT signaling cascade (Myers et al. 2008).”
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875 · cited 6×
“As indicated above, melatonin exerts its physiological functions through its chronobiotic, anti-excitatory, antioxidant, anti-inflammatory, immunomodulatory and vasomotor activities (Pandi-Perumal et al. 2006).”
InfluentialObesity, insulin resistance and free fatty acids
Boden, G. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283444b09 · Cited by 848 · cited 1×
“In this regard, several mechanisms in connection with increased body fat accumulation and insulin resistance have been proposed including, amongst others, generation of lipid metabolites, inflammation, and cellular stress (oxidative and endoplasmic reticulum stress) (for review see Boden (2011)).”
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
Cited by
Melatonin: Exceeding Expectations
Reiter, R. J., Tan, D. X., & Galano, A. (2014) · Physiology · doi:10.1152/physiol.00011.2014 · Cited by 605
The Effects of Light at Night on Circadian Clocks and Metabolism
Fonken, L. K., & Nelson, R. J. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1051 · Cited by 460
Hardeland, R. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12090 · Cited by 284
Szewczyk‐Golec, K., Woźniak, A., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12257 · Cited by 153
Bahrami, M., Cheraghpour, M., Jafarirad, S., Alavinejad, P., Asadi, F., Hekmatdoost, A., Mohammadi, M., & Yari, Z. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102452 · Cited by 60
Pleiotropic Effects of Melatonin
Mahmood, D. (2019) · Drug Research · doi:10.1055/a-0656-6643 · Cited by 52
Yang, W., Tang, K., Wang, Y., Zhang, Y., & Zan, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12780-y · Cited by 50
Nduhirabandi, F., Huisamen, B., Strijdom, H., Blackhurst, D., & Lochner, A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12171 · Cited by 48
“The pineal gland hormone melatonin has recently attracted the attention of many researchers in obesityrelated disorders [11].”
BackgroundMethodResultSelf-citationMohammadi, S., Rastmanesh, R., Jahangir, F., Amiri, Z., Djafarian, K., Mohsenpour, M. A., Hassanipour, S., & Ghaffarian-Bahraman, A. (2021) · BioMed Research International · doi:10.1155/2021/3502325 · Cited by 22
Metadata
- Authors
- Nduhirabandi, F., du Toit, E. F., & Lochner, A.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2012-02-03
- Volume
- 205
- Issue
- 2
- Pages
- 209-223
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2136530496
- Cited by
- 116
- References
- 25
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.